scholarly journals 5 YEARS INTRAVESICAL INSTILLATION WITH MITOMYCIN-C AND PIRARUBICIN AS A PROPHYLACTIC TREATMENT FOR SUPERFICIAL BLADDER CANCER

2006 ◽  
Vol 97 (4) ◽  
pp. 636-641
Author(s):  
Shuichiro Kobayashi ◽  
Kaoru Oka ◽  
Tatsuya Machida ◽  
Kazuhiro Ishizaka
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Prophylactic Treatment ◽  
Superficial Bladder Cancer ◽  
Intravesical Instillation

scholarly journals PROPHYLACTIC INTRAVESICAL INSTILLATION THERAPY WITH ADRIAMYCIN (ADM) AND MITOMYCIN C (MMC) IN PATIENTS WITH SUPERFICIAL BLADDER CANCER

1986 ◽  
Vol 77 (9) ◽  
pp. 1493-1500 ◽  
Author(s):  
Yujiro Ozaki ◽  
Tomoyasu Tsushima ◽  
Yasutomo Nasu ◽  
Takafumi Akagi ◽  
Tsuneaki Obama ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Superficial Bladder Cancer ◽  
Intravesical Instillation ◽  
Instillation Therapy

Endovesical Prophylactic Mitomycin C Chemotherapy in Superficial Bladder Cancer: A Retrospective Study

1993 ◽  
Vol 60 (4) ◽  
pp. 320-324 ◽  
Author(s):  
C. Boccafoschi ◽  
D. Tiranti ◽  
F. Montefiore ◽  
S. Annoscia ◽  
A. Di Mauro ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Retrospective Study ◽  
Mitomycin C ◽  
Patient Group ◽  
Prophylactic Treatment ◽  
Superficial Bladder Cancer ◽  
Progression Rate ◽  
Recurrent Carcinoma

The Authors report the results of a retrospective study concerning the use of mitomycin C in the prophylactic treatment of superficial bladder cancer after trans-urethral resection. The series includes 113 patients; minimum follow-up: 6 months, maximum 54, mean 17.7 months. Recurrence and progression rate was evaluated at 6, 12, 24, and 36 months. The cumulative recurrence and progression rate was 16.8% and 6.1% respectively. Patients with pTa neoplasms didn't develop progressions. G2 and G3 carcinoma recurrence and progression rate was higher than with G1 tumours. Multifocal neoplasms showed a higher trend recurrence compared to solitary tumours. The number of recurrences in the patient group with primitive neoplasms was not significantly different from that of patients with recurrent carcinoma.

Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer

1987 ◽  
Vol 20 (S1) ◽  
Author(s):  
Tomoyasu Tsushima ◽  
Yosuke Matsumura ◽  
Yujiro Ozaki ◽  
Jun Yoshimoto ◽  
Hiroyuki Ohmori ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Superficial Bladder Cancer ◽  
Intravesical Instillation ◽  
Instillation Therapy

1570: Combined Mitomycin C and Hyperthermia (SYNERGO) for Patients with Superficial Bladder Cancer (SBC) after Bacillus Calmette-Guerin (BCG) Failure

2007 ◽  
Vol 177 (4S) ◽  
pp. 519-519
Author(s):  
Ofer Nativ ◽  
Renzo Colombo ◽  
Dov Engelstein ◽  
Ofer N. Gofrit ◽  
Thomas Akkad ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Superficial Bladder Cancer ◽  
Bacillus Calmette Guerin ◽  
Bcg Failure

832: Optimized Intravesical Mitomycin C Treatment for Superficial Bladder Cancer: Long-Term Follow-Up

2006 ◽  
Vol 175 (4S) ◽  
pp. 268-269 ◽  
Author(s):  
Jessie L. Au ◽  
Robert A. Badalament ◽  
M. Guillaume Wientjes ◽  
Donn C. Young ◽  
Tong Shen ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Superficial Bladder Cancer ◽  
Long Term Follow Up

A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer

1994 ◽  
Vol 35 (S1) ◽  
pp. S31-S35 ◽  
Author(s):  
Kikuo Okamura ◽  
Tatsuro Murase ◽  
Koji Obata ◽  
Shinichi Ohshima ◽  
Yoshinari Ono ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Randomized Trial ◽  
Superficial Bladder Cancer ◽  
Intravesical Instillation
Sign in / Sign up

Export Citation Format

Share Document